Waystar AI Delivers Industry-Leading Outcomes, Earns #1 Client Ranking
Black Book survey of more than 750 healthcare leaders demonstrates that Waystar leads the industry in client satisfaction with AI...
Month: February 2026
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE THE EMPLOYEE HEALTH AND SAFETY SOFTWARE BUSINESS OF UL SOLUTIONS
AUSTIN, Texas, Feb. 20, 2026 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading private investment firm...
Orrum Announces Strategic Partnership with LivaNova to Unite Intelligent Data with Innovative Perfusion Technology
Orrum's CŌRE Insights™ analytics platform will be available through an automatic integration for LivaNova's Essenz Perfusion SystemPLYMOUTH, Mich., Feb. 20,...
Cardiac Surgeons at Allegheny General Hospital First in Region to Successfully Perform Transcatheter Tricuspid Valve Replacement Procedure
PITTSBURGH, Feb. 20, 2026 /PRNewswire/ -- Cardiac experts from Pittsburgh's Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) announced today they...
TRNR Publishes CEO Letter Discussing Recent Deal & Company Next Steps
AUSTIN, TEXAS / ACCESS Newswire / February 20, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of...
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
Continued CEO Investment Signals Alignment with Shareholders and Confidence in Long-Term Corporate Strategy MESA, ARIZONA / ACCESS Newswire / February...
Andrew Cannestra, MD PhD Urges Healthcare Leaders to Rethink Innovation from the Ground Up
From San Francisco, Dr. Andrew Cannestra is advocating for systems-level thinking to drive smarter, real-world medical solutions. SAN FRANCISCO, CA...
Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split
AUSTIN, TEXAS / ACCESS Newswire / February 20, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of...
Waystar Rated #1 Overall in Black Book’s Q1 2026 Agentic and Generative AI Revenue Cycle Management Benchmark
New study of 774 hospital and medical group revenue cycle leaders finds payer-change responsiveness, auditability, and support performance are now...
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
Company achieves minimum stockholders' equity rule; Nasdaq confirms matter is closedAspire maintains listing on the Nasdaq ESTERO, FL / ACCESS...
SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings
NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today...
Annual General Meeting in ALK-Abelló A/S on 16 March 2026
The Annual General Meeting of ALK-Abelló A/S (ALKB:DC / Nasdaq Copenhagen: ALK B) will take place on Monday, 16 March...
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology...
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
GAITHERSBURG, Md., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market leader in cutting-edge, AI-powered...
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI response Durable Clinical Observations and Favorable Safety...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the...
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
Regulatory clearance enables start of clinical testing and marks transition to clinical-stage companyOn track for initial clinical data to emerge...
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Approval
Enables Potential Shorter Time to Accelerated Approval of PDS0101 in HPV16-positive Head and Neck CancerPRINCETON, N.J., Feb. 20, 2026 (GLOBE...
Nasus Pharma to Participate in Upcoming Investor Conferences
TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage...